WIPO’s COVID-19 Related Services and Support

WIPO Director General Daren Tang launched a package of support measures to assist member states in addressing the COVID-19 pandemic and building back better as part of their sustainable post-COVID economic recovery efforts. In October 2021, WIPO member states approved this WIPO COVID-19 response package as part of its Program of Work and Budget 2022/23 .

The package aims to help member states deal with the pandemic, as well as leverage intellectual property (IP) to support creativity, innovation and the entrepreneurship needed for job creation, investment, enterprise growth and socio-economic development.

The response package will be tailored to meet the individual needs of member states and will adapt as the pandemic evolves. WIPO, via the COVID-19 Focal Point, will engage in a continuous dialogue with member states, and is open to their requests for targeted and customized support with respect to national priorities and challenges.

In March 2022, briefing sessions were held for Member States to provide information about the planned and ongoing activities under the response package and how to access support.

Contact

Member states seeking more information should contact Mr. Sherif Saadallah, Executive Director of the WIPO Academy and Focal Point on WIPO’s Package of COVID-19 support.

Member states seeking more information on the WHO-WIPO-WTO Trilateral Cooperation relating to COVID-19 should contact Ms. Amy Dietterich, Director of the Global Challenges Division.

Areas of support

unilateral-covid19-845 — (Photo: Orbon Alija/ E+/ Getty Images)

Bilateral technical assistance

Tailored support to member states for COVID-19 economic recovery projects, including policy and legislative advice.

trilateral-covid19-845 — (Photo: Who_I_am/ iStock/ Getty Images)

Trilateral cooperation

Access resources at the intersection of IP, health, and trade through the WHO-WIPO-WTO trilateral cooperation.

policy-covid19-845 — (Photo: 101cats/ iStock/ Getty Images)

Policy and legislative assistance

Legislative and policy advice relating to IP, innovation and creativity.

skills-covid19-845 — (Photo: nd3000/ iStock/ Getty Images)

Skills and capacity building

Practical skills-building and training opportunities offered by the WIPO Academy.

tisc-covid19-845 — (Photo: ipopba/ iStock/ Getty Images)

Innovation support

Access to specific policy, decision making and tools to respond to COVID-19 issues through WIPO Technology and Innovation Support Centers (TISCs).

IP dispute resolution

WIPO Arbitration and Mediation Center services catered to the life sciences sector.

Knowledge resources

COVID-19 IP Policy Tracker

WIPO tracks and provides information on measures adopted by IP offices in response to the COVID-19 pandemic, including information connected to deadlines, legislative responses and other regulatory measures.
Database on Flexibilities in the IP System

The Database on Flexibilities in the IP System contains data drawn from WIPO documents on Patent Related Flexibilities in the Multilateral Legal Framework and their Legislative Implementation at the National and Regional Levels. It allows searches for implementation of flexibilities in national IP laws in selected jurisdictions.
Pat-INFORMED

The Patent Information Initiative for Medicines (Pat-INFORMED) provides easy access to medicine patent information to the global health community, particularly those involved in procurement of medicines. Users can easily find information on a medicine’s patent status in a particular country and other available information on PATENTSCOPE, WIPO’s own global patent database. Pat-INFORMED also provides a facility for procurement agencies to make follow-up inquiries directly with participating companies.
Patent Landscape Reports (PLR) and analytics

Patent Landscape Reports are a way of using patent information and data to gather and share insights on technology developments. WIPO has supported the WHO and local vaccine manufacturing discussions with its PLR on vaccines; licensing and public procurement discussions; and decisions of the Medicines Patent Pool related to antirotrevirals (ritonavir and Atazanavir). WIPO has also collected publicly available PLRs and has put together a searchable compilation.
PATENTSCOPE COVID-19 Index

PATENTSCOPE launched a COVID-19 search facility to provide scientists, engineers, public health policymakers, industry actors and members of the general public with an easily accessible source of intelligence for improving the detection, prevention, and treatment of diseases such as the novel coronavirus.

Dozens of search queries are now available, specially curated by patent information experts who have identified technological areas relevant to the detection, prevention and treatment of COVID-19 are available.